In B-cell lymphoma, IMP2 acts upon the cell cycle and regulates proliferation by binding to and stabilizing NT5DC2, which is involved in the metabolism of nucleotides by hydrolysis and is implicated in the progression of cancer [103]. The gene discussed is IGF2BP2; the disease is cancer.